Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tasco Holdings International is the parent company of Acadian Seaplants, a global leader in the development of seaweed-based biotechnology for the animal, plant, and human health sectors. Headquartered in Nova Scotia, Canada, the company specializes in the sustainable harvesting and processing of Ascophyllum nodosum to create high-value bioactive ingredients. Its flagship animal health brand, Tasco, is a scientifically proven prebiotic that enhances immune function and heat stress resistance in livestock and companion animals. Acadian Seaplants operates multiple state-of-the-art manufacturing facilities and maintains a robust R&D program focused on marine plant science. The company's products are utilized in over 80 countries, supporting sustainable agriculture and animal nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tasco Holdings International.